Tailor-Made Solutions for Improving Oncologist Access

Posted by Jon Roffman on Wed, Sep 25, 2013

If you have been an oncology sales rep (or witnessed one in action), you know the difficulty in reaching many oncologists. According to ZS’s latest AccessMonitor report, 65% of oncologists put “moderate to severe” restrictions on sales rep access (compared to 58% of cardiologists and 47% of primary care doctors).

Considering the industry’s sizable investment in oncology, pharmaceutical companies can’t simply ignore these restrictions and hope things get better on their own.


>
Read More